- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Visen Pharmaceuticals (2561)
Visen Pharmaceuticals stock price live, this page displays HK 2561 stock exchange data. View the 2561 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Visen Pharmaceuticals real time stock price chart below.
What Is the Visen Pharmaceuticals Stock Price Today?
The Visen Pharmaceuticals stock price today is 46.02.
What Is the Stock Symbol for Visen Pharmaceuticals?
The stock symbol for Visen Pharmaceuticals is ""2561.""
What Stock Exchange Does Visen Pharmaceuticals Trade On?
Visen Pharmaceuticals is listed and trades on the Hong Kong stock exchange.
Is Visen Pharmaceuticals a Good Stock to Buy?
Determining whether Visen Pharmaceuticals—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2561 quote. (ISIN: KYG93Y5D1039)
What Is the Visen Pharmaceuticals Stock Price Today?
The Visen Pharmaceuticals stock price today is 46.02.
What Is the Stock Symbol for Visen Pharmaceuticals?
The stock symbol for Visen Pharmaceuticals is ""2561.""
What Stock Exchange Does Visen Pharmaceuticals Trade On?
Visen Pharmaceuticals is listed and trades on the Hong Kong stock exchange.
Is Visen Pharmaceuticals a Good Stock to Buy?
Determining whether Visen Pharmaceuticals—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2561 quote. (ISIN: KYG93Y5D1039)
Hong Kong
Currency in HKD
46.02
-0.24(-0.52%)
Delayed Data·
Fair Value
An estimate of a Visen Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
45.98
46.28
52 wk Range
39.25
69.15
2561 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
2561 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Visen Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
45.9846.28
52 wk Range
39.2569.15
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2561 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Visen Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
82.97
Upside
+80.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Visen Pharmaceuticals Company Profile
VISEN Pharmaceuticals, an investment holding company, engages in the development and commercialization of endocrine therapies in the People’s Republic of China, Hong Kong, and Taiwan. Its lead product, Lonapegsomatropin, is a once-weekly long-acting growth hormone replacement therapy for the treatment of pediatric growth hormone deficiency. The company also develops TransCon CNP (navepegritide), a long-acting prodrug of c-type natriuretic peptide for the treatment of achondroplasia; and Palopegteriparatide, a once-daily parathyroid hormone replacement therapy for the treatment of chronic hypoparathyroidism. It has strategic collaboration agreements with Shanghai Pharmaceutical and the United Family Healthcare. The company was incorporated in 2018 and is headquartered in Suzhou, China.
Compare 2561 to Peers and Sector
Metrics to compare | 2561 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2561PeersSector | |
|---|---|---|---|---|
P/E Ratio | −26.5x | −31.4x | −0.5x | |
PEG Ratio | −0.98 | −0.36 | 0.00 | |
Price/Book | 20.0x | 5.7x | 2.6x | |
Price / LTM Sales | 1,736.9x | 12.6x | 3.3x | |
Upside (Analyst Target) | 78.6% | −6.9% | 43.3% | |
Fair Value Upside | Unlock | 2.2% | 6.9% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 82.97
(+80.29% Upside)
Earnings
Latest Release
Apr 30, 2025
EPS / Forecast
-5.65 / --
Revenue / Forecast
-48,000.00 / --
FAQ
What Stock Exchange Does Visen Pharmaceuticals Trade On?
Visen Pharmaceuticals is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for Visen Pharmaceuticals?
The stock symbol for Visen Pharmaceuticals is "2561."
What Is the Visen Pharmaceuticals Market Cap?
As of today, Visen Pharmaceuticals market cap is 5.27B.
What Is Visen Pharmaceuticals's Earnings Per Share (TTM)?
The Visen Pharmaceuticals EPS (TTM) is -1.95.
From a Technical Analysis Perspective, Is 2561 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Visen Pharmaceuticals Stock Split?
Visen Pharmaceuticals has split 0 times.
How Many Employees Does Visen Pharmaceuticals Have?
Visen Pharmaceuticals has 58 employees.
What is the current trading status of Visen Pharmaceuticals (2561)?
As of 11 Aug 2025, Visen Pharmaceuticals (2561) is trading at a price of 46.02, with a previous close of 46.26. The stock has fluctuated within a day range of 45.98 to 46.28, while its 52-week range spans from 39.25 to 69.15.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.